These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 17392531

  • 21. [Drug therapy of hyperglycemia and the prognosis of adult-onset diabetes mellitus].
    Niskanen L, Uusitupa M, Laakso M.
    Duodecim; 1999; 115(10):1122-4. PubMed ID: 11877851
    [No Abstract] [Full Text] [Related]

  • 22. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
    Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association, European Association for Study of Diabetes.
    Diabetes Care; 2009 Jan; 32(1):193-203. PubMed ID: 18945920
    [Abstract] [Full Text] [Related]

  • 23. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR.
    Diabetologia; 2012 Jun; 55(6):1577-96. PubMed ID: 22526604
    [No Abstract] [Full Text] [Related]

  • 24. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.
    Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B.
    Diabetologia; 2008 Jan; 51(1):8-11. PubMed ID: 18026926
    [No Abstract] [Full Text] [Related]

  • 25. Prospective study of hyperglycemia and cancer risk: response to Stattin et al.
    Bowker SL, Johnson JA.
    Diabetes Care; 2007 Jul; 30(7):e77; author reply e78. PubMed ID: 17596500
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
    Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL, American Diabetes Association, American College of Cardiology Foundation.
    Diabetes Care; 2008 Apr; 31(4):811-22. PubMed ID: 18375431
    [No Abstract] [Full Text] [Related]

  • 28. [Glycemic control and cardiovascular diseases in type 2 diabetes].
    Madsbad S.
    Ugeskr Laeger; 2008 Nov 03; 170(45):3634. PubMed ID: 18986612
    [No Abstract] [Full Text] [Related]

  • 29. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.
    Lund SS, Vaag AA.
    Diabetes Care; 2009 Jul 03; 32(7):e90-1; author reply e92-3. PubMed ID: 19564469
    [No Abstract] [Full Text] [Related]

  • 30. American Diabetes Association. Resource guide 2005. Class action: type 2 pills update.
    McCarren M.
    Diabetes Forecast; 2005 Jan 03; 58(1):RG6-9. PubMed ID: 15714615
    [Abstract] [Full Text] [Related]

  • 31. Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes.
    Nolan JJ.
    Diabetologia; 2010 Jul 03; 53(7):1247-9. PubMed ID: 20419286
    [No Abstract] [Full Text] [Related]

  • 32. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.
    Krentz A.
    Diabetes Metab Res Rev; 2009 Feb 03; 25(2):112-26. PubMed ID: 19219860
    [Abstract] [Full Text] [Related]

  • 33. Aggressive treatment of type 2 diabetes: a managed care consensus statement.
    Manag Care Interface; 2003 Feb 03; Suppl A():14-8. PubMed ID: 12564407
    [No Abstract] [Full Text] [Related]

  • 34. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association.
    Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA.
    Diabetes Care; 2006 Dec 03; 29(12):2739-48. PubMed ID: 17130218
    [No Abstract] [Full Text] [Related]

  • 35. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS, American Diabetes Association, American College of Cardiology Foundation, American Heart Association.
    J Am Coll Cardiol; 2009 Jan 20; 53(3):298-304. PubMed ID: 19147051
    [No Abstract] [Full Text] [Related]

  • 36. Should the algorithm for the treatment of type 2 diabetes be evidence-based?
    Guillausseau PJ.
    Diabetologia; 2010 Sep 20; 53(9):2076-7. PubMed ID: 20607513
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. To what extent is the new position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 'personalised'?
    Ceriello A, Gallo M, Gentile S, Giorda CB, De Micheli A, Associazione Medici Diabetologi (AMD).
    Diabetologia; 2012 Oct 20; 55(10):2853-2855. PubMed ID: 22801904
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
    Laakso M.
    Nat Clin Pract Cardiovasc Med; 2008 Nov 20; 5(11):682-3. PubMed ID: 18797431
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.